Roivant Sciences: Diverse Exposure To Biotech Niches Through Vants
Roivant Sciences: Diverse Exposure To Biotech Niches Through Vants
Similar Posts
End of Summer Sale | Save 50%
(Image credit: Future) Invest smarter with Britain’s best-selling financial magazine. Benefit from expert analysis on investments, stocks and shares, pension planning and more. Take advantage of our End of Summer Sale offer and get 50% off your first quarter – sale ends 15 September. (Image credit: Future) Your first 13 weeks for just £32.99 £16.48 (that’s 50% off the subscription…
Nvidia’s $63 Billion Investment Portfolio Has a New No. 2 Holding
Key Points Although Nvidia is best-known for its dominance in artificial intelligence (AI)-accelerated data centers, it’s also quite the investor. A sizeable investment in AI start-up xAI has paid significant dividends since the start of the year. However, Nvidia’s second-largest investment is facing a myriad of challenges as a newly public company. 10 stocks we…
Baidu, Inc. (BIDU) Q2 2026 Earnings Call Transcript
Operator Hello and thank you for standing by for Baidu’s Second Quarter 2026 Earnings Conference Call. [Operator Instructions] Today’s conference is being recorded. [Operator Instructions] I would now like to turn the meeting over to your host for today’s conference, Juan Lin, Baidu’s Director of Investor Relations. Juan LinDirector of Investor Relations Hello, everyone, and…
Wheat Posting a Wednesday Morning Rebound
Wheat is trading with gains across the complex. The wheat complex was under pressure on Tuesday, with the three markets falling lower. Chicago SRW contracts were 11 to 14 cents in the red. Open interest rose 1,994 contracts. KC HRW futures were 9 1/2 to 11 1/4 cents lower across the board. MPLS spring wheat…
TTM Technologies: Upgrading To Buy, Shares Look Cheap
TTM Technologies: Upgrading To Buy, Shares Look Cheap
